Home/ Supplements/ Niacin/ Gugu Lipo

Gugu Lipo

product on market Capsule Priority One Nutritional Supplements Safety: 95/100
95/100

This product looks safe

  • Niacin: 138mg is 3.9× the Tolerable Upper Intake Level (35mg)
  • 62% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

This formula combines chromium and acetyl L-carnitine, which have moderate evidence for supporting glucose metabolism and energy production. Guggul gum and garlic are included for lipid support, though clinical evidence for their efficacy is more limited. The ingredient profile is generally considered safe for most users.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 138mg is 3.9× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for Gugu Lipo
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Vegetarian Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
62%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

138 mg NE (859% DV)
Exceeds UL by 3.9× (UL: 35 mg) 196 studies (A:5, B:63)
50 mcg (143% DV)
1.4× RDA — within safe limits 199 studies (A:1, B:55)
Market median: 500.0mg (861 products) 61 studies (A:4, B:13)
Guggul Gum Extract
250 mg
250 mg
Market median: 500.0mg (497 products) 135 studies (A:0, B:40)
Onion
10 mg
Market median: 300.0mg (159 products)
Market median: 250.0mg (337 products) 127 studies (A:1, B:41)

Other Ingredients

Rice Chelate Silicon Dioxide Hypromellose Water, Purified
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Recommendations: Take two (2) capsules twice daily (preferably with a meal) or as directed by your physician.

Warnings & Precautions

Warning: Persons with liver disease or inflammatory bowel disease should consult their physician before use.

Keep out of reach of children.

Formulation Notes

Contains no preservatives.

Vegetarian formulation

Non-GMO

Additional Information

Keep container tightly closed, store in a cool, dry place.

Bisphenol-A (BPA) & Phthalate Free

GMP Certified

For professional use only.

Metadata

Product Details

UPC / SKU8 15354 02062 4
DSLD Entry Date2022-11-22
Product TypeOther Combinations
FormCapsule
BrandPriority One Nutritional Supplements
DSLD ID277364
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

Serotone 5HTP 50 mg
Higher Nature · Capsule
100
Serotone 5HTP 100 mg
Higher Nature · Capsule
100
ChromeMate
NOW · Capsule
100
ChromeMate 200 mcg
Protocol For Life Balance · Capsule
100
Non Flush Niacin
Highland Laboratories · Capsule
100
View all Niacin products →
Niacin research Best Niacin All Niacin products More from Priority One Nutritional Supplements View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.